RTC
ATRC icon

Riverview Trust Company’s AtriCure ATRC Stock Holding History

Riverview Trust Company’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-325
Closed -$13K – 714
2022
Q3 		$13K Hold
325
– – 0.01% 492
2022
Q2 		$13K Buy
+325
New +$15.4K 0.01% 538

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Riverview Trust Company's ATRC Position: Q4 2022 in Review

Riverview Trust Company sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 325 shares — an estimated $13K sold.

Riverview Trust Company first reported a position in ATRC in Q2 2022 and held it in 2 quarters. The position peaked at $13K in Q3 2022. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

  • Riverview Trust Company reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
  • Riverview Trust Company sold 325 AtriCure shares in Q4 2022, an estimated $13K.
  • Riverview Trust Company first reported a position in AtriCure in Q2 2022 and held it in 2 quarters.
  • Riverview Trust Company's AtriCure position peaked at $13K in Q3 2022.
  • 211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on Riverview Trust Company's 13F filing for Q4 2022, filed 26 Jan 2023.